Filing Details

Accession Number:
0001104659-14-020868
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-19 12:20:38
Reporting Period:
2014-03-18
Filing Date:
2014-03-19
Accepted Time:
2014-03-19 12:20:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1497504 Dipexium Pharmaceuticals Inc. DPRX Pharmaceutical Preparations (2834) 271707962
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1601121 G. Robert Shawah C/O Dipexium Pharmaceuticals, Llc
74 Broad Street
New York NY 10004
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.001 Per Share Acquisiton 2014-03-18 500 $12.00 500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $.001 Per Share Employee Stock Option (right to buy) Acquisiton 2014-03-18 85,379 $0.00 85,379 $13.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
85,379 2019-03-18 No 4 A Direct
Footnotes
  1. The option vests in 36 equal monthly installments, with the first installment vesting on April 18, 2014.